Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Liu 2018 Atherosclerosis Suppl"

From Bioblast
Line 2: Line 2:
|title=Liu D (2018) Enhanced Trpc3-mediated mitochondrial respiratory dysfunction by inhibition of mitochondria-hexokinase in monocytes from hypertension rats. Atherosclerosis Suppl.
|title=Liu D (2018) Enhanced Trpc3-mediated mitochondrial respiratory dysfunction by inhibition of mitochondria-hexokinase in monocytes from hypertension rats. Atherosclerosis Suppl.
|info=[https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30342-8/abstract Atherosclerosis]
|info=[https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30342-8/abstract Atherosclerosis]
|authors=Liu D
|authors=Liu Daoyan
|year=2018
|year=2018
|event=Atherosclerosis Suppl
|event=Atherosclerosis Suppl

Revision as of 18:52, 29 February 2020

Liu D (2018) Enhanced Trpc3-mediated mitochondrial respiratory dysfunction by inhibition of mitochondria-hexokinase in monocytes from hypertension rats. Atherosclerosis Suppl.

Link: Atherosclerosis

Liu Daoyan (2018)

Event: Atherosclerosis Suppl

Inhibition of transient receptor potential channel, canonical type 3 (TRPC3) attenuates monocytes and vasculature calcium influx in spontaneously hypertensive rats (SHRs). However, it remains elusive whether mitochondrial TRPC3 participates in increasing mitochondrial calcium homeostasis and ROS production in monocytes from hypertension.


β€’ Bioblast editor: Plangger M, Kandolf G β€’ O2k-Network Lab: CN Chongqing Zhu Z


Labels: MiParea: Respiration, nDNA;cell genetics 


Organism: Rat  Tissue;cell: Blood cells  Preparation: Intact cells 


Coupling state: ROUTINE, OXPHOS, ET  Pathway: N, NS  HRR: Oxygraph-2k 


Affiliations

Daping Hospital, Third Military Medical Univ, Chongqing, China